People with post-traumatic stress disorder (PTSD) who use marijuana experience fewer symptoms and recover more quickly compared to people who don’t use cannabis, a U.S. Department of Veterans Affairs researcher said in a new podcast posted by the agency. Hal Wortzel, a VA forensic neuropsychiatrist, talked about the findings... Read more
“We could raise a whole bunch of money and potentially cut property taxes.” By Ethan DeWitt, New Hampshire Bulletin The bills have bipartisan support. Their sponsors include left-leaning Democrats and libertarian Republicans. One has been advanced by a Republican chairman of an influential committee; another by the House Democratic... Read more
“We could raise a whole bunch of money and potentially cut property taxes.” By Ethan DeWitt, New Hampshire Bulletin The bills have bipartisan support. Their sponsors include left-leaning Democrats and libertarian Republicans. One has been advanced by a Republican chairman of an influential committee; another by the House Democratic... Read more
Pfizer Inc., one of the trifecta pharmaceutical companies manufacturing COVID-19 vaccines, is acquiring another large pharma company that is conduction clinical trials on a variety of drugs, including one that is examining the efficacy of cannabinoids. Pfizer Inc. announced the planned acquisition of Arena Pharmaceuticals, Inc. on December 13.... Read more
Japanese video game powerhouse Capcom revealed last week that it is lending its hit character Ace Attorney to a campaign designed to prevent cannabis use by young people. The company announced on Thursday that characters from the popular video game series will be enlisted to fight youth cannabis use... Read more
In a sign that things are absolutely at a tipping point in Europe, the Mediterranean island of Malta became the first country in both Europe and the European Union (EU) to legalize recreational cannabis cultivation, possession and use. Luxembourg announced similar plans (and a similar model) about a month... Read more
Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company Sale supports the Company’s strategic focus on driving demand for cannabis and cannabinoid-based consumer products SMITHS FALLS, ON and NEUMARKT-IN-DER-OBERPFALZ, Germany, Dec. 15, 2021 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC)has entered into an agreement to divest its subsidiary... Read more
SKYT Stock Sell-Off Presents Aggressive Opportunity Newly issued stocks have taken a beating this year. The Renaissance IPO ETF (NYSEARCA:IPO) has fallen by 16% over the past three months, while the S&P 500 has advanced five percent. While the initial public offering (IPO) segment tends to be riskier because... Read more
